NOTE 2 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS



As of September 30, 2020, the Company had cash of $650 and a working capital deficit (current liabilities in excess of current assets) of $83,791,130. During the nine months ended September 30, 2020, the net loss available to common stockholders was $142,405,892 and net cash used in operating activities was $717,062. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for one year from the issuance of the unaudited condensed consolidated financial statements.



During the nine months ended September 30, 2020, the Company received proceeds of $637,000 and $132,911 from the issuance of convertible notes and non-convertible notes, respectively. The Company does not have sufficient cash to fund operations for the next fiscal year.



The Company’s primary source of operating funds since inception has been cash proceeds from the public and private placements of the Company’s securities, including debt and equity securities, and proceeds from the exercise of warrants and options. The Company has experienced net losses and negative cash flows from operations since inception and expects these conditions to continue for the foreseeable future. The Company’s ability to continue its operations is dependent upon its ability to obtain additional capital through public or private equity offerings, debt financings or other sources; however, financing may not be available to the Company on acceptable terms, or at all. The Company’s failure to raise capital as and when needed could have a negative impact on its financial condition and its ability to pursue its business strategy, and the Company may be forced to curtail or cease operations.



Management’s plans regarding these matters encompass the following actions: 1) obtain funding from new and current investors to alleviate the Company’s working capital deficiency; and 2) implement a plan to increase revenues. The Company’s continued existence is dependent upon its ability to translate its audience into revenues. However, the outcome of management’s plans cannot be determined with any degree of certainty.

volume dropping like a nickle off of a table

next week it is only going to get worse

lol, that has been evident from day one


the problem is no one wants to believe the truth

Not sure but it sure seems like the FDA Approval fairy tale has sorta played itself out

sells outnumbering buys at more than 6 to 1

now that was a nail biter

green and holding 25.20 cost average, now back to the original plan

yes, with volume....

I read it as a registration statement for shares previously issued on a Private Placement Memorandum.

Those shares issued are now free trading and I would like to know what price the shares were issued originally

One thing I don't like is that a form 4 was filed by Chamath Palihapitya for 3.8mm shares sold between 24.67 and 27.54 just a couple of day ago

makes me wonder if he had advanced knowledge of the registration and traded accordingly

I am long and fully expect SPCE to return to recent highs but I also think they had better start with the press to let people know what the plan might be... otherwise left to our own thinking some will for sure fear the worst

anyone know the issuance price of the private placement

"A lot of insiders buying up cheep shares"

got any sort of basis for that statement or is it just one of those things that sounds good?

you might want to look into the history of Dennis Alexander

I have clearly shown where the deal was rescinded and there has not been any evidence what so ever that would indicate that the pending FDA Approval has anything to do with BSSP

I would suggest a quick phone call to either Harry Z. Diane Z. or Dannie Z

that would certainly clear things up for you

How about you show me anything dated after October 2017 that connects BSSP to Cantech

it seems as though the Cantech Holding on the WY SOS site sorta says that the Cantech that BSSP was once connected with is no longer



so once again... show me something that demonstrates BSSP is related to Cantech Pharma that is dated after October 2017

I have not said that Cantech Pharma does not have FDA Approval pending, I just say that BSSP has no connection to Cantech Pharma

You don't think if Dennis Alexander finally for once in his life attempted something that actually worked out that he wouldn't be issuing press??

great... registering shares

added at 23.60

average now 25.20

This prospectus relates to the resale of up to 112,964,840 shares of our common stock by the selling stockholders named in this prospectus or their permitted transferees, which includes up to 104,964,840 outstanding shares of our common stock and up to 8,000,000 shares of our common stock that are issuable upon the exercise of warrants to purchase our common stock that were initially issued in connection with a private placement. We are registering the shares for resale pursuant to such stockholders’ registration rights under a registration rights agreement between us and such stockholders. Subject to any contractual restrictions on them selling the shares of our common stock they hold, the selling stockholders may offer, sell or distribute all or a portion of their shares of our common stock publicly or through private transactions at prevailing market prices or at negotiated prices. We will not receive any of the proceeds from the sale of the shares of our common stock owned by the selling stockholders. We will bear all costs, expenses and fees in connection with the registration of these shares of our common stock, including with regard to compliance with state securities or “blue sky” laws. The selling stockholders will bear all commissions and discounts, if any, attributable to their sale of shares of our common stock.

"astrological type of statements"

lmfao

the press release you are linking to is from 2016

this profile on OTC Markets (you know... the site that operates the exchange) says the deal was rescinded in October 2017

The Art of Selling a Losing Position

Your stock is losing value. You want to sell, but you can't decide in favor of selling now, before further losses, or later when losses may or may not be larger. All you know is that you want to offload your holdings and preserve your capital and reinvest the money in a more profitable security. In a perfect world, you'd always achieve this aim and sell at the right time.


Unfortunately, it isn't that easy in real life. When the housing bubble burst in 2007 and stocks started their descent into a bear market, investors froze like deer caught in a grizzly's jaws. Many didn't even react until the value of their portfolio holdings had declined by as much as 50% to 60%.

sounds pretty familiar........doesn't it

anyone starting to get the picture??

lmmfao......

crickets.............

volume drying up

dumps at the bid outweigh buys at the ask by 4 to 1



Won't be long now

RUH ROH

lol

does anyone wonder why Dennis has not released press in regard to the pending FDA Approval??

I can tell you why.... because it has nothing to do with BSSP. If it did, don't you think there would be press??

this is just about played out. Not very many people still believe

if you really want to know who bought shares of this pig above .0004

call PT Barnum

A quick look at OTC Markets should clear this up

didn't dip low enough to double the position but at least those 26.81's are in the vicinity of green

going back to recent highs

The problem with the volume just trickling in for the .0002's is that if they do get taken out who will be stupid enough to bag themselves in .0003's??

there are so many different stocks making great moves everyday, why hang with a dead money dead beat like Dennis Alexander?

when those .0001's start to fall they are going to disappear fast... really fast

Short Float 27.89%

Oh, that doesn't matter around here

I didn't add today.

maybe tomorrow

there it went

.0001 x .0002

I have done all the digging I need to do. I did not believe it in the first place by I was willing to give the benefit of the doubt until I made a few phone calls

the FDA approval has absolutely nothing to do with BSSP


45,861,821 (.0002) x 176,529,487 (.0003)

people starting to pull bids at .0002

91,892,952 x 158,990,393

those .0002's might be gone by today's close

which means the issuance of more discounted shares

gonna have to raise the authorized

https://www.foxbusiness.com/technology/virgin-galactic-wall-street-favorite-despite-rocket-snafu

there is no news because they have nothing to say

the pending FDA Approval that is being used as pump spew has nothing to do with BSSP

people should take the time to make a few phone calls, but I guess most would rather not know the truth

not a big enough dip this morning to add a second 1000 to the 26.81 average but IMO as soon as news of the date of another test launch is announced SPCE will be all over the recent highs

the harsh reality is... If Dennis Alexander/BSSP were in anyway involved with the FDA approval Dennis would be screaming it from the rooftops

seriously... consider that

getting out at .0002 will be on a first come first serve basis

don't be left holding this bag like so many others have had to do for the last 4 years. They are all long gone and you should be too

$20,000 sitting on the bid and $60,000 sitting on the ask

volume is waning and it is going to be an uphill battle for those that actually believe the spew

zero bid by Friday

that look you get when you realize the circus left town and you didn't leave with them

I am,

bought premarket at 26.81

when it starts to move back toward 32 I will sell the covered calls and bank twice

pretty much a no brainer at current levels